Document is current
Any future updates will be listed below
-
Authors
Golding, Michael A.
Baldwin, Sarah
Kim, Brandon
Harbottle, Zoe
Bhamra, Manvir
Mackay, Dylan S.
Ben-Shoshan, Moshe
Gerdts, Jennifer D.
Abrams, Elissa M.
Penner, Sara J.
St-Vincent, Jo-Anne
Protudjer, Jennifer L. P.
-
Funding
Funding for this research was provided by:
Candian Institutes of Health Research
Max Rady College of Medicine, University of Manitoba
- License Information
-
More Information
Article History
Received: 1 May 2025
Accepted: 6 August 2025
First Online: 21 August 2025
Declarations
:
: This study was approved by the University of Manitoba Health Research Ethics Board (HS2022:025 (HS25330)). All participants provided their informed consent before participating.
: Not applicable.
: MBS: serves on several advisory boards, including Food Allergy Canada, Novartis, Sanofi, and Stallergenes Greer. He also reports personal fees from Bausch Health, Novartis, Sanofi, and Stallergenes Greer. Additionally, he has received grants from Stallergenes Greer and has participated in clinical trials conducted by Aimmune Therapeutics, Novartis, and Sanofi. JP: is Section Head, Allied Health, and Co-Lead, Research Pillar, Canadian Society of Allergy and Clinical Immunology; and is on the steering committee for Canada’s National Food Allergy Action Plan. She reports consulting for Ajinomoto Cambrooke, Novartis, Nutricia and ALK Abelló.
